Ultralife Corporation (NASDAQ:ULBI - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.54 and traded as high as $8.77. Ultralife shares last traded at $8.62, with a volume of 25,652 shares trading hands.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded shares of Ultralife from a "buy" rating to a "strong-buy" rating in a research report on Friday, June 6th.
Get Our Latest Analysis on ULBI
Ultralife Stock Performance
The stock's 50-day moving average price is $7.12 and its 200-day moving average price is $6.53. The company has a current ratio of 3.22, a quick ratio of 1.70 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $142.38 million, a P/E ratio of 26.75 and a beta of 1.00.
Ultralife (NASDAQ:ULBI - Get Free Report) last released its earnings results on Friday, May 9th. The technology company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.02). The company had revenue of $50.75 million for the quarter, compared to analyst estimates of $54.50 million. Ultralife had a net margin of 3.05% and a return on equity of 4.61%. During the same period in the previous year, the business posted $0.21 EPS.
Insider Buying and Selling
In related news, Director Bradford T. Whitmore acquired 11,980 shares of the stock in a transaction that occurred on Friday, May 23rd. The shares were purchased at an average cost of $5.41 per share, with a total value of $64,811.80. Following the completion of the transaction, the director owned 1,060,067 shares of the company's stock, valued at approximately $5,734,962.47. This trade represents a 1.14% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Thomas Louis Saeli bought 5,000 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $5.44 per share, with a total value of $27,200.00. Following the completion of the transaction, the director directly owned 85,000 shares of the company's stock, valued at approximately $462,400. This represents a 6.25% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 47,140 shares of company stock worth $256,355 over the last quarter. Insiders own 40.00% of the company's stock.
Institutional Trading of Ultralife
A number of institutional investors and hedge funds have recently modified their holdings of the company. Visionary Wealth Advisors raised its stake in Ultralife by 17.1% during the 4th quarter. Visionary Wealth Advisors now owns 1,292,836 shares of the technology company's stock valued at $9,632,000 after purchasing an additional 188,384 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Ultralife during the 4th quarter valued at $522,000. Renaissance Technologies LLC raised its stake in Ultralife by 11.6% during the 4th quarter. Renaissance Technologies LLC now owns 256,090 shares of the technology company's stock valued at $1,908,000 after purchasing an additional 26,700 shares during the last quarter. Nuveen LLC acquired a new position in Ultralife during the 1st quarter valued at $116,000. Finally, JPMorgan Chase & Co. raised its stake in Ultralife by 45.3% during the 4th quarter. JPMorgan Chase & Co. now owns 68,952 shares of the technology company's stock valued at $514,000 after purchasing an additional 21,494 shares during the last quarter. 30.68% of the stock is currently owned by institutional investors and hedge funds.
About Ultralife
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
See Also
Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
